Science news articles about 'non alcoholic steatohepatitis'

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are well-recognized causes of progressive liver disease leading to cirrhosis and hepatocellular carcinoma. To date, ...

... than those of control group. At the end of 12th wk, the rats presented the pathology of steatohepatitis with higher serum levels of endotoxin, D-xylose in model group than those of control group. The ...

Nonalcoholic steatohepatitis (NASH) is a disorder characterized by hepatic steatosis, inflammation and fibrosis with a risk of developing cirrhosis and hepatocellular carcinoma (HCC). The progression ...

... diabetes often occurs as part of the metabolic syndrome, which increases the risk of non-alcoholic steatohepatitis (NASH), which can lead to liver cancer. Chronic hepatitis C also increases the risk ...

... ranges from hepatic steatosis (fat accumulation in the liver cells) to the more severe non-alcoholic steatohepatitis (NASH) and fibrosis that can progress to cirrhosis, end-stage liver disease, and ...

... chronic hepatitis C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty liver ... link between ferritin and steatosis in a non-obese cohort of non-alcoholic patients. In southern European ...

... inbred strains of mice and discovered that one strain, named C57BL/6J, was susceptible to non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma on a high-fat, but not a low-fat diet. The ...